Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_assertion type Assertion NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_head.
- NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_assertion description "[Loss of imprinting at insulin-like growth factor II (IGFII), in association with H19 silencing, has been described previously in a subgroup of Beckwith-Wiedemann syndrome (BWS) patients who have an elevated risk for Wilms' tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_provenance.
- NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_assertion evidence source_evidence_literature NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_provenance.
- NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_assertion SIO_000772 17325026 NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_provenance.
- NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_assertion wasDerivedFrom befree-2016 NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_provenance.
- NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_assertion wasGeneratedBy ECO_0000203 NP595987.RAQEY3UBzEj9r_Ldi_0a_GbHODO8KHf0ynlX6FCiSqSOE130_provenance.